RoboNeuroendocrine tumors (NETs) are a rare group of cancers that develop from hormone-producing cells. Although they account for less than 1% of all cancers, their incidence has been steadily increasing worldwide.
A recent study conducted at Hôtel-Dieu de France in Beirut provides valuable insights into how these tumors present and evolve in the Lebanese population.
What Are Neuroendocrine Tumors?
Neuroendocrine tumors can develop in different organs, but they are most commonly found in the digestive system, including:
• Stomach
• Pancreas
• Small intestine
• Colon
• Liver
These tumors vary significantly in behavior, some grow slowly, while others are more aggressive and require prompt treatment.
Key Findings from the Study
The study analyzed patients diagnosed with gastroenteropancreatic neuroendocrine tumors (GEP-NETs) between 2013 and 2024.
Several important trends were identified:
1. Increasing Detection of More Aggressive Tumors
Compared to previous years, a higher proportion of patients were diagnosed with moderate to high-grade tumors, which tend to grow faster and behave more aggressively.
2. Shift in Tumor Locations
The study showed:
• More tumors originating in the pancreas and liver
• Fewer cases in the colon and duodenum
This shift may influence both diagnosis and treatment strategies.
3. Advanced Disease at Diagnosis
A significant number of tumors, particularly colorectal neuroendocrine tumors, were already metastatic at the time of diagnosis, meaning the disease had spread.
4. Impact of External Factors
The increase in advanced cases may be linked to:
• Delayed diagnosis
• Reduced access to healthcare
• The impact of the COVID-19 pandemic
• Socioeconomic challenges
These factors highlight the importance of timely medical evaluation.
Why Early Diagnosis Matters
Neuroendocrine tumors are often silent in early stages, with non-specific symptoms such as:
• Abdominal discomfort
• Digestive changes
• Unexplained weight loss
Early detection significantly improves treatment options and outcomes.
A Multidisciplinary Approach to Care
Management of neuroendocrine tumors requires coordination between:
• Surgeons
• Gastroenterologists
• Oncologists
• Radiologists
Surgical treatment remains a key component, especially when tumors are detected early or can be safely removed.
Takeaway
This study highlights a clear trend toward more advanced and aggressive neuroendocrine tumors at diagnosis in recent years.
The key message is simple:
Early evaluation and timely diagnosis are essential.
If you experience persistent digestive symptoms or have been diagnosed with a gastrointestinal condition, seeking specialized medical assessment can make a significant difference.
